BioVie Pharma (BIVI) Return on Sales by Net Profit

biovieinc.com - graphic logo of issuer BIVI

Investor confidence in BioVie Inc. (BIVI) is highly volatile and depends on the outcomes of clinical trials. The sales margin value visualizes this dependency, reaching the 0.00 mark. Developments in the field of severe liver pathologies ensure stable demand. Further stimulus is provided by research on the drug NE3107 against neurodegeneration, which opens prospects for strategic partnerships with pharmaceutical behemoths.

biovieinc.com (BIVI) - Company Sales Margin from 07/04/2022 to 11/19/2026

biovieinc.com (BIVI) - metric breakdowns and financial figures

- market value and analyst target forecast:
- market capitalization details:
Analysis of all company metrics:BioVie Inc.
Finished products of BioVie Inc.

Sales margins determine the share of net profit in every dollar of revenue, reflecting the ultimate operational efficiency of the business. This metric measures a company's ability to convert revenue into real capital after deducting all expenses. By analyzing the net profit margin of BioVie Inc. (BIVI) on GURU.Markets, an investor sees the current value of assets without time lags. For BioVie Inc. (BIVI), this indicator reflects the cost of maintaining an elite staff of neurodegenerative disease researchers. High expenditures on innovators directly impact current profitability.